000 01480 a2200433 4500
005 20250518045212.0
264 0 _c20191206
008 201912s 0 0 eng d
022 _a1527-3172
024 7 _a10.37757/MR2018.V20.N3.6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOchoa-Azze, Rolando F
245 0 0 _aEffectiveness of a Serogroup B and C Meningococcal Vaccine Developed in Cuba.
_h[electronic resource]
260 _bMEDICC review
_c07 2018
300 _a22-29 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAge Factors
650 0 4 _aBacterial Capsules
_ximmunology
650 0 4 _aBrazil
_xepidemiology
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aColombia
_xepidemiology
650 0 4 _aCuba
650 0 4 _aDisease Outbreaks
_xprevention & control
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMeningococcal Infections
_xepidemiology
650 0 4 _aMeningococcal Vaccines
_ximmunology
650 0 4 _aNeisseria meningitidis, Serogroup B
_ximmunology
650 0 4 _aNeisseria meningitidis, Serogroup C
_ximmunology
650 0 4 _aPolysaccharides, Bacterial
_ximmunology
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aGarcía-Imía, Luis
700 1 _aVérez-Bencomo, Vicente
773 0 _tMEDICC review
_gvol. 20
_gno. 3
_gp. 22-29
856 4 0 _uhttps://doi.org/10.37757/MR2018.V20.N3.6
_zAvailable from publisher's website
999 _c29838807
_d29838807